Drap directs pharma firms to recall 3 ‘substandard’ syringes

Published
0

The Drug Regulatory Authority of Pakistan (Drap) on Tuesday directed three pharmaceutical companies to recall “substandard” medical devices from the market and advised pharmacists and chemists to stop supplying these products.

“[The] Central Drugs Laboratory Karachi informed the Drug Regulatory Authority of Pakistan that the samples of the below-mentioned medical devices have been declared as ‘Substandard’,” an alert issued by Drap stated.

The alert identified Zindagi Auto Disable Syringe 5ml, the Ultra Fine SMD Painless Syringe 5ml and Ultra Fine SMD Painless Syringe 3ml as the substandard devices.

“Use of these syringes, in invasive or intravenous procedures, poses a significant risk of introducing microbial contaminants into the patient’s body, which may result in localised infections, abscesses, or life-threatening systemic infections, particularly in immunocompromised individuals,” Drap said.

“All pharmacists and chemists working at distribution and pharmacies should immediately check their stocks and stop supplying the mentioned products,” the statement said, adding that the remaining stocks should be quarantined and returned to the supplier or the company.

The Zindagi Auto Disable Syringe was declared “substandard” on the basis of a sterility test, while the Ultra Fine SMD Painless Syringes were declared “substandard” on the basis of a sterility test and description test with “clear visible black particles found in the barrel of the syringe”.

The alert advised consumers to stop using products bearing the affected batch number and contact their physician or healthcare provider if they experienced any problems that may be related to using the items. It further urged them to report the incident to Drap.

Last year in March, Drap directed a pharmaceutical company to recall a syrup, which is given to children to treat fever, from the market and advised health professionals not to prescribe it.

In January 2024, Drap directed pharmaceutical companies to recall nine contaminated syrups, according to its chief executive officer.

Opinion

Editorial

Restructuring plans
Updated 29 Oct, 2026

Restructuring plans

The primary reason for governance failure in Pakistan is not the geographical size of the existing provinces but the reluctance of provincial capitals to empower local bodies.
Polluted priorities
Updated 29 Oct, 2026

Polluted priorities

Enforcement must continue, but decisions should follow evidence, not the visibility of machinery on city roads.
Continuing genocide
29 Oct, 2026

Continuing genocide

FOR the people of Gaza, despite the ‘ceasefire’ reached last October, the genocide never really ceased. This ...
Regional security
Updated 28 Oct, 2026

Regional security

Iran and the Makkah pact states should pledge not to let external actors use their soil to launch aggression against each other.
Rate hike
28 Oct, 2026

Rate hike

THE SBP’s decision to raise its policy rate by 50 basis points to 12pc was largely expected. It is also justified...
Press solidarity
28 Oct, 2026

Press solidarity

PAKISTAN’S journalists have seldom lacked organisations speaking in defence of press freedom. What has been ...